Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease

(2020) Jacqueline B. Henson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

(2020) Silvia Sookoian et al.   GUT

Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease

(2020) James M. Paik et al.   HEPATOLOGY

Update on NAFLD genetics: from new variants to the clinic

(2020) Eric Trépo et al.   JOURNAL OF HEPATOLOGY

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

(2020) Giovanni Targher et al.   GUT

Nonalcoholic Steatohepatitis

(2020) Adam C. Sheka et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation

(2020) Xiaoyan Cai et al.   LIVER INTERNATIONAL

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?

(2020) Maria Corina Plaz Torres et al.   Cancers

Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?

(2020) Mireia Alemany-Pagès et al.   BMC PUBLIC HEALTH

Associations Between Reproductive and Hormone-related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population

(2020) Jun Wang et al.   Clinical Gastroenterology and Hepatology

Comparison of MAFLD and NAFLD diagnostic criteria in real world

(2020) Su Lin et al.   LIVER INTERNATIONAL

Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review and meta‐analysis

(2020) Callum John Baker et al.   Journal of Diabetes

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

(2020) Tracey G Simon et al.   GUT

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

(2020) Sakura Yamamura et al.   LIVER INTERNATIONAL

2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial

(2020) Ahmad Al-Mrabeh et al.   Lancet Diabetes & Endocrinology

Redefining fatty liver disease: an international patient perspective

(2020) Gamal Shiha et al.   Lancet Gastroenterology & Hepatology

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

(2020) Hokyou Lee et al.   Clinical Gastroenterology and Hepatology

Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis

(2020) Alessandro Mantovani et al.   GUT

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

(2020) Nahum Mendez-Sanchez et al.   Lancet Gastroenterology & Hepatology

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

(2020) Gamal Shiha et al.   Lancet Gastroenterology & Hepatology

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease

(2020) Erica Jennison et al.   Clinical and Molecular Hepatology

MAFLD and risk of CKD

(2020) Dan-Qin Sun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

(2020) Philip N. Newsome et al.   NEW ENGLAND JOURNAL OF MEDICINE

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

(2019) Michael E J Lean et al.   Lancet Diabetes & Endocrinology

Nonalcoholic Fatty Liver Disease and the Heart

(2019) Eric P. Stahl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes

(2019) Ralph A DeFronzo et al.   Diabetes & Vascular Disease Research

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

(2019) Amedeo Lonardo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy

(2019) Stephen P. Chelko et al.   CIRCULATION

The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study

(2019) Alina M. Allen et al.   JOURNAL OF HEPATOLOGY

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

(2018) Michael EJ Lean et al.   LANCET

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis

(2018) Alessandro Mantovani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease

(2018) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

(2018) Alessandro Mantovani et al.   THYROID

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR

(2018) Mayada Metwally et al.   JOURNAL OF HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis

(2017) Kongkiat Chaikriangkrai et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Treatment of NAFLD with diet, physical activity and exercise

(2017) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis

(2017) Christina N Katsagoni et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Inflammation, metaflammation and immunometabolic disorders

(2017) Gökhan S. Hotamisligil   NATURE

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography

(2017) Harvey Hecht et al.   Journal of Cardiovascular Computed Tomography

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis

(2017) Giovanni Musso et al.   JAMA Internal Medicine

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus

(2016) Kenneth Cusi et al.   ANNALS OF INTERNAL MEDICINE

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) et al.   DIABETOLOGIA

Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis

(2016) Dong Hyun Sinn et al.   GASTROENTEROLOGY

Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study

(2016) Dong Hyun Sinn et al.   GUT

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

(2016) Matthew James Armstrong et al.   LANCET

Nonalcoholic fatty liver disease and hepatocellular carcinoma

(2016) Heinz Zoller et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice

(2016) Gustavo Monnerat et al.   Nature Communications

Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients

(2015) Leslee J. Shaw et al.   ANNALS OF INTERNAL MEDICINE

Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes

(2015) Hajime Yamazaki et al.   DIABETES CARE

Low Awareness of Nonalcoholic Fatty Liver Disease Among Patients at High Metabolic Risk

(2015) Amanda C. Wieland et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

(2015) Giovanni Targher et al.   Metabolic Syndrome and Related Disorders

Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population

(2015) Chi‐Sheng Hung et al.   Journal of the American Heart Association

Comparison of cardiovascular disease risk calculators

(2014) G. Michael Allan et al.   CURRENT OPINION IN LIPIDOLOGY

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis

(2013) Na Wu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Resolution of Fatty Liver and Risk of Incident Diabetes

(2013) Ki-Chul Sung et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Muscles, exercise and obesity: skeletal muscle as a secretory organ

(2012) Bente K. Pedersen et al.   Nature Reviews Endocrinology

Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wild-type Mice

(2011) Michihiro Mutoh et al.   GASTROENTEROLOGY

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis

(2011) V. W.-S. Wong et al.   GUT

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

(2011) Zeneng Wang et al.   NATURE

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

(2010) Eek Joong Park et al.   CELL

Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988-2006

(2010) C. C. Cowie et al.   DIABETES CARE

Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1- and -R2-Mediated AMPK Activation

(2010) A Young Kim et al.   MOLECULAR ENDOCRINOLOGY

Radiation Dose Associated With Common Computed Tomography Examinations and the Associated Lifetime Attributable Risk of Cancer

(2009) Rebecca Smith-Bindman   ARCHIVES OF INTERNAL MEDICINE

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE